NCT04870255View on ClinicalTrials.gov

Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS

NARecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Depressive Disorder, MajorBorderline Personality Disorder
Interventions
DEVICE

Left Dorsolateral Prefrontal Cortex (L-DLPFC)

"Participants who are randomly assigned to this group will receive active iTBS (intermittent theta burst stimulation) to the left DLPFC. Stimulation intensity will be standardized at 90% of resting motor threshold (adjusted for cortical depth).~Stimulation will be delivered using the Magventure Magpro X100 TMS system."

DEVICE

Dorsomedial Prefrontal Cortex (DMPFC)

"Participants who are randomly assigned to this group will receive active iTBS (intermittent theta burst stimulation) to the DMPFC. Stimulation intensity will be standardized at 100% of resting motor threshold (adjusted for cortical depth).~Stimulation will be delivered using the Magventure Magpro X100 TMS system."

DEVICE

Sham Stimulation

"Participants who are randomly assigned to this group will receive sham stimulation to the left DLPFC.~Sham stimulation will be delivered using the Magventure Magpro X100 TMS system."

Trial Locations (1)

94305

RECRUITING

Stanford Hospital, Stanford

All Listed Sponsors
lead

Stanford University

OTHER